Physician profile

Brett Jay Arbon

Nurse Practitioner · Pleasant View, UT

NPI 1578527909

$3,071.84

in general payments reported to CMS, 2019-2025

39 companies · $790 in 2025

The $790 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,933.34

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $736.78 2021-2025
Pfizer INC. $300.84 2021-2025
Glaxosmithkline, LLC. $260.80 2021-2025 Trelegy Ellipta, Shingrix, Arexvy
Astellas Pharma US INC $200.75 2021-2025 Veozah, Myrbetriq
Astrazeneca Pharmaceuticals LP $171.96 2021-2025 Farxiga, Airsupra
Lilly USA, LLC $118.67 2021-2025 Mounjaro, Zepbound, Jardiance
Dynavax Technologies Corporation $116.93 2021-2025 Heplisav-B
Organon LLC $94.97 2022-2025 Nexplanon
Ironshore Pharmaceuticals INC. $79.43 2021-2023 Jornay Pm
Baxter Healthcare $76.00 2023-2024 Hillrom - Carnation Ambulatory Monitor, Hillrom - Life 2000 Ventilation System
Biohaven Pharmaceutical Holding Company LTD. $68.50 2022
Amarin Pharma, INC. $67.54 2021-2022
Dexcom, INC. $62.43 2024-2025 Dexcom G6 Transmitter
Amgen INC. $51.22 2021-2022
Janssen Pharmaceuticals, INC $48.94 2023 Spravato
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $48.92 2021-2022
Novo Nordisk INC $47.27 2024-2025
Biohaven Pharmaceuticals, INC. $40.47 2021
Abbott Laboratories $38.60 2022
Otsuka America Pharmaceutical, INC. $36.19 2024-2025 Rexulti, Jynarque
Merck Sharp & Dohme LLC $35.47 2024-2025 Capvaxive, Gardasil 9, Vaxelis
Takeda Pharmaceuticals U.S.A., INC. $33.69 2021-2023 Trintellix
Boston Scientific Corporation $32.36 2023 Wavewriter Alpha Prime 16
Axsome Therapeutics, INC. $30.03 2025 Auvelity
Sanofi Pasteur INC. $29.25 2022-2023
Jazz Pharmaceuticals INC. $26.60 2021
Corium, LLC $23.61 2025 Azstarys
Genzyme Corporation $22.31 2023
Cranial Technologies, INC $19.64 2025 Doc Band
Phathom Pharmaceuticals, INC. $18.06 2025 Voquezna
Becton, Dickinson and Company $17.76 2024 Bd Surepath Collection Vial
Corcept Therapeutics $16.88 2024 Korlym
Horizon Therapeutics Plc $15.59 2021
Treace Medical Concepts, INC. $14.53 2024
Sobi, INC $14.42 2022
Sanofi-Aventis U.S. LLC $14.38 2025
Genentech USA, INC. $13.90 2021
Biogen, INC. $13.52 2025 Zurzuvae
E.R. Squibb & Sons, L.L.C. $12.63 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brett Jay Arbon

$3,071.84

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $790 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

https://glasscript.com/doctor/10985484/brett-jay-arbon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.